Symbol
4D Molecular Therapeutics, Inc.
Full name of the company.
MEDICAL-DRUGS
Industry name
DRUGS
Major industry name
Medical
Sector name
$3.28
Current price of the stock
$1M
Trading volume of the stock
$182.2M
Market capitalization of the company
Micro Cap
Category of market capitalization
35.65%
Long-term growth mean estimate
4.30
Mean analyst rating
948.78%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
17.33
Current ratio
100.00%
Gross profit margin
-1704400.00%
Operating profit margin
-1704400.00%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-1461433.00%
Pretax profit margin
-1461433.00%
Net profit margin
-7.93%
Measures profitability relative to shareholders' equity
-7.93%
ROE excluding intangible assets
-7.26%
Measures profitability relative to total assets
-7.93%
Measures profitability relative to invested capital
0.00
Asset turnover ratio
-
Inventory turnover ratio
-
Receivables turnover ratio
-
Average number of days it takes to collect receivables
-1.18
Measures valuation relative to earnings
-
P/E based on future earnings estimates
10123.17
Measures valuation relative to sales
0.31
Measures valuation relative to book value
-0.63
Measures valuation relative to operating cash flow
-0.61
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
